ArticlePLOS global public health2026
The role of faith-based organizations in the pharmaceutical systems of low-and-middle-income countries - A scoping review.
Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In many low- and middle-income countries (LMICs), faith-based organizations (FBOs) play a critical role in ensuring access to essential pharmaceutical services. Despite their longstanding presence in this role, there are few existing reviews describing the contributions of FBOs to pharmaceutical systems in LMICs. This study aims to provide a structured overview of the existing literature on FBO engagement in pharmaceutical systems across LMICs. This study utilizes the Pharmaceutical Systems Strengthening (PSS) Framework to categorize FBO contributions across key components of the pharmaceutical system. A scoping review, guided by the Arksey & O'Malley approach, was undertaken. Searches focused on English-language literature from 2000 onward across multiple databases. Two reviewers independently screened titles and abstracts, and relevant full texts were analyzed to extract the contributions of FBOs. We identified 524 papers, with 30 meeting inclusion criteria after eligibility assessment. These studies spanned 21 LMICs, 19 of which were in Africa, and documented FBO contributions across five religions: Christianity (N = 30), Islam (N = 4), Hinduism (N = 1), Sikhism (N = 1), and Buddhism (N = 1). While FBO engagement is noted in all pharmaceutical system components, the most documented FBO contributions were in: financing (donations, pooled procurement and drug revolving funds), regulatory systems (quality and safety surveillance), human resources (capacity building) and pharmaceutical products and services (operating outlets that supply pharmaceutical products, promoting increased uptake and adherence). Findings also highlighted that FBOs collaborate within and across sectors. However, there remains a paucity of data on evaluating FBO contributions. This scoping review highlights the diverse roles of FBOs in pharmaceutical systems across all components of the PSS framework to address critical system gaps. The overrepresentation of Christian FBOs in the literature underscores the need to further explore engagement across other religious traditions. A critical gap identified is the lack of rigorous measurement of FBO outcomes and impact.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.